ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Medexus Pharmaceuticals Inc

Medexus Pharmaceuticals Inc (MDP)

7.75
0.00
(0.00%)
終了 1月27日 6:00AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
7.75
買値
7.80
売値
7.85
出来高
-
0.00 日の範囲 0.00
7.75 52 週間の範囲 7.75
時価総額
前日終値
7.75
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
-
発行済株式数
24,458,000
配当利回り
-
PER
-566.67
1 株当たり利益 (EPS)
-0.01
歳入
113.05M
純利益
-214k

Medexus Pharmaceuticals Inc について

セクター
Pharmaceutical Preparations
業界
Blank Checks
ウェブサイト
本社
Bolton, Gbr
設立
2013
Medexus Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the トロントベンチャー取引所 with ticker MDP. The last closing price for Medexus Pharmaceuticals was $7.75. Over the last year, Medexus Pharmaceuticals shares have traded in a share price range of $ 7.75 to $ 7.75.

Medexus Pharmaceuticals currently has 24,458,000 shares in issue. The market capitalisation of Medexus Pharmaceuticals is $189.55 million. Medexus Pharmaceuticals has a price to earnings ratio (PE ratio) of -566.67.

MDP 最新ニュース

Complete Response Letter Received from FDA for Treosulfan

TORONTO and CHICAGO and WEDEL, Germany, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”) announced...

Medexus Appoints New Chief Financial Officer

TORONTO and CHICAGO, July 19, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) is pleased to announce the appointment of Marcel Konrad...

Medexus Pharmaceuticals and medac GmbH enter into Licensing Agreement for First-in-Class Conditioning Agent, Treosulfan, in C...

TORONTO and CHICAGO and WEDEL, Germany, July 12, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has entered...

Medexus Receives Notice of Compliance to Commercialize Treosulfan in Canada

TORONTO and CHICAGO, June 28, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSX: MDP) (OTCQX: MEDXF) today announced that it has received a Notice of...

Medexus Revenue Increases 43.5% to a Record US$79.7 Million for Fiscal 2021

Transformative licensing agreement for treosulfan in the U.S. completed February 2, 2021 Cash and cash equivalents of $18.7 million and available liquidity of $24.8 million at March 31, 2021...

Medexus Announces Graduation to the Toronto Stock Exchange

TORONTO and CHICAGO and MONTREAL, June 15, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSXV:MDP) (OTCQX: MEDXF) announced today that it has received final...

Medexus to Present at Raymond James Human Health Innovation Conference

TORONTO, CHICAGO and MONTREAL, June 14, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

Medexus Schedules Fiscal Year 2021 Conference Call

TORONTO and CHICAGO and MONTREAL, June 11, 2021 (GLOBE NEWSWIRE) -- , June 11, 2021 - Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today...

Medexus Strengthens Medical Affairs Team in Preparation for Planned Treosulfan Launch

TORONTO, CHICAGO and MONTREAL, June 10, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) today announced that it...

Medexus Announces Availability of Triamcinolone Hexacetonide in the United States

TORONTO and CHICAGO and MONTREAL, June 09, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1007.757.757.7500CS
4007.757.757.7500CS
12007.757.757.7500CS
26007.757.757.7500CS
52007.757.757.7500CS
156007.757.757.7500CS
2604.05109.4594594593.79.751.4279666.84598439CS

MDP - Frequently Asked Questions (FAQ)

What is the current Medexus Pharmaceuticals share price?
The current share price of Medexus Pharmaceuticals is $ 7.75
How many Medexus Pharmaceuticals shares are in issue?
Medexus Pharmaceuticals has 24,458,000 shares in issue
What is the market cap of Medexus Pharmaceuticals?
The market capitalisation of Medexus Pharmaceuticals is CAD 189.55M
What is the 1 year trading range for Medexus Pharmaceuticals share price?
Medexus Pharmaceuticals has traded in the range of $ 7.75 to $ 7.75 during the past year
What is the PE ratio of Medexus Pharmaceuticals?
The price to earnings ratio of Medexus Pharmaceuticals is -566.67
What is the cash to sales ratio of Medexus Pharmaceuticals?
The cash to sales ratio of Medexus Pharmaceuticals is 1.07
What is the reporting currency for Medexus Pharmaceuticals?
Medexus Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Medexus Pharmaceuticals?
The latest annual turnover of Medexus Pharmaceuticals is USD 113.05M
What is the latest annual profit for Medexus Pharmaceuticals?
The latest annual profit of Medexus Pharmaceuticals is USD -214k
What is the registered address of Medexus Pharmaceuticals?
The registered address for Medexus Pharmaceuticals is 35 NIXON ROAD, UNIT 1, BOLTON, L7E 1K1
What is the Medexus Pharmaceuticals website address?
The website address for Medexus Pharmaceuticals is www.medexus.com
Which industry sector does Medexus Pharmaceuticals operate in?
Medexus Pharmaceuticals operates in the BLANK CHECKS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
ADEAdex Mining Inc
$ 0.01
(100.00%)
1,000
DEALPlaygon Games Inc
$ 0.02
(100.00%)
1.75M
TVC.HThree Valley Copper Corp
$ 0.01
(100.00%)
15.6k
GBUGabriel Resources Ltd
$ 0.01
(100.00%)
167k
MACThemac Resources Group Ltd
$ 0.08
(60.00%)
3k
NAVNAVCO Pharmaceuticals Inc
$ 0.005
(-50.00%)
16.63k
SMAR.PSmartset Services Inc
$ 0.015
(-50.00%)
30k
ETUE2gold Inc
$ 0.005
(-50.00%)
101.7k
DDDMetavista3D Inc
$ 2.30
(-49.45%)
701.59k
MXL.HMX Gold Corp
$ 0.04
(-46.67%)
1.5k
NDANeptune Digital Assets Corp
$ 2.20
(30.18%)
5.15M
BRCBlackrock Silver Corp
$ 0.355
(-11.25%)
3.79M
TDGTDG Gold Corp
$ 0.45
(-1.10%)
3.19M
GPUSAlset AI Ventures Inc
$ 0.14
(-12.50%)
2.79M
PNGKraken Robotics Inc
$ 2.87
(0.35%)
2.69M

最近閲覧した銘柄